Shining a Light on Blood Cancer

Blood Cancer Awareness Month 1

EHA Launches Digital Campaign

In September 2021, the European Hematology Association (EHA) will honor Blood Cancer Awareness Month with an extensive digital campaign. From promoting individual awareness days to related EHA projects and stakeholders, EHA will ‘shine a light' on September, highlighting its commitment to working, “towards a cure for all blood disorders”.

There are a wide range of blood cancer types, and many are pervasive in Europe. According to the International Agency for Research on Cancer, Europe shows the highest combined rates of prevalence of Hodgkin and non-Hodgkin lymphoma, leukemia, and multiple myeloma in 2020, at 27.3 per 100,000. This places hematological malignancies close to the heart of EHA, and emphasizes the importance of patient organizations and awareness of the many forms of blood cancer.

Alongside awareness days for CLL, lymphoma, CML, cancer research, EHA will spotlight Big Data in hematology and the HARMONY Alliance, part of the IMI 'Big Data for Better Outcomes' program. On September 30, 2021, HARMONY Alliance will also launch the first Big Data for Blood Cancer Awareness Day.The HARMONY Alliance works towards Big Data analytics, which will accelerate better and faster treatment for blood cancer patients. 

EHA will also spotlight our partners in immunotherapy. These partners include T2EVOLVE, whose goal is to accelerate the development of CAR T-cell therapy, and the GoCART Coalition, which supports access to new cellular therapies for patients.

To support further education among clinicians and researchers, EHA is hosting several meetings during September, including blood cancer topics in their discussions. In conjunction with the Lebanese Society for Hematology and Blood Transfusion, EHA has organized the Virtual Hematology Update “Bleeding disorders & multiple myeloma,” where participants will join faculty in learning about new research in the field. To bring tailored information from the EHA2021 Congress to a focused, regional audience, the Highlights of Past EHA (HOPE) Asia and HOPE Middle East/North Africa (MENA) meetings have been scheduled for September 10-11 and 23-24, respectively, to further disseminate new research on benign and malignant hematology.

We encourage you to stay tuned throughout the month of September for further updates about EHA projects, events, and partners and international awareness days, and to 'shine a light' on not only blood cancer awareness, but also toward a cure for all blood order disorders.

Last Updated on Monday 04 October 2021.